Igm Biosciences Inc (IGMS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 2,679 | 2,130 | 1,069 | 0 | 0 |
| Gross Profit | 2,679 | 2,130 | 1,069 | N/A | N/A |
| Operating Expenses | 211,259 | 265,591 | 229,025 | 165,323 | 83,280 |
| Operating Income | -208,580 | -263,461 | -227,956 | -165,323 | -83,280 |
| Other Income | 12,785 | 17,723 | 6,854 | 159 | 1,925 |
| Pre-tax Income | -195,795 | -245,738 | -221,102 | -165,164 | -81,355 |
| Income Tax | N/A | 678 | N/A | N/A | N/A |
| Net Income Continuous | -195,795 | -246,416 | -221,102 | -165,164 | -81,355 |
| Net Income | $-195,795 | $-246,416 | $-221,102 | $-165,164 | $-81,355 |
| EPS Basic Total Ops | -3.24 | -4.71 | -5.32 | -4.93 | -2.65 |
| EPS Basic Continuous Ops | -3.24 | -4.71 | -5.32 | -4.93 | -2.65 |
| EPS Diluted Total Ops | -3.24 | -4.71 | -5.32 | -4.93 | -2.65 |
| EPS Diluted Continuous Ops | -3.24 | -4.71 | -5.32 | -4.93 | -2.65 |
| EPS Diluted Before Non-Recurring Items | -3.24 | -4.71 | -5.32 | -4.93 | -2.65 |
| EBITDA(a) | $-206,351 | $-264,324 | $-224,594 | $-160,215 | $-82,278 |